Public comments invited till 25th April, 2024 on draft of revised guidance for industry to align with the New Drugs and Clinical Trials (NDCT) Rules, 2019 and Sugam application process (Version 1.2) by Anum Ahmed | Apr 19, 2024 | Central, OPS, PharmaceuticalsWith a view to align the submission procedure of clinical trial application (as prescribed under... Read More
Health Ministry sets 31st December, 2024 as implementation date for Jan Vishwas Act amendments to Drugs and Cosmetics Act, 1940; drug manufacturers may be subject to increased fines for utilizing government analysts’ reports in advertisements by Anum Ahmed | Apr 4, 2024 | Central, OPS, PharmaceuticalsPursuant to the Update reported earlier on Jan Vishwas (Amendment of Provisions) Act 2023 (please... Read More
Health Ministry revises Drugs Rules 1945; permits tablet and capsule quantities exceeding 10 to be packaged in multiples of both 7 and 5 by Anum Ahmed | Mar 21, 2024 | Central, OPS, PharmaceuticalsIn furtherance to what we reported earlier (please refer to e-mails in trail), the Ministry of... Read More
A regulatory recap for the Pharmaceutical Sector- Decoding some key updates/developments in the month of November, 2021 by Lexplosion | Jan 11, 2022 | Compliance, Legal analysisThe Indian pharmaceutical industry has been undergoing substantial changes in the realm of... Read More
NCT, Delhi orders authorized dealers of pulse Oxymeter and Oxygen Concentrator to display the Stock position and MRP of these devices at their premises for general public by Anum Ahmed | May 28, 2021 | Delhi, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More